E-LIB Suche - Ergebnisse für: Michal Becker-Cohen

1

Venglustat in GBA1-related Parkinson's disease:

Zimran, Ari ; Revel-Vilk, Shoshana ; Becker-Cohen, Michal..
The Lancet Neurology. 23 (2024) 2 - p. 137 , 2024

2

GBA1-Associated Parkinson's Disease Is a Distinct Entity:

Skrahin, Aliaksandr ; Horowitz, Mia ; Istaiti, Majdolen...
International Journal of Molecular Sciences. 25 (2024) 13 - p. 7102 , 2024

Link: https://doi.org/10.3390/..

3

The Bone Biomarker of Quantitative Chemical Shift Imaging i..:

Zimran, Ari ; Szer, Jeff ; Becker-Cohen, Michal...
Journal of Clinical Medicine. 12 (2023) 6 - p. 2220 , 2023

Link: https://doi.org/10.3390/..

4

Ambroxol therapy for patients with Gaucher disease type 1, ..:

Istaiti, Majdolen J. ; Becker-Cohen, Michal ; Frydman, Dafna...
Molecular Genetics and Metabolism. 138 (2023) 2 - p. 107165 , 2023

Link: https://doi.org/10.1016/..

5

Contribution of lyso-Gb1 to treatment decisions in patients..:

Dinur, Tama ; Bauer, Peter ; Beetz, Christian...
Molecular Genetics and Metabolism. 138 (2023) 2 - p. 107080 , 2023

Link: https://doi.org/10.1016/..

6

Contribution of Glucosylsphingosine (Lyso-Gb1) to Treatment..:

Dinur, Tama ; Bauer, Peter ; Beetz, Christian...
International Journal of Molecular Sciences. 24 (2023) 4 - p. 3945 , 2023

Link: https://doi.org/10.3390/..

7

Prodromal Parkinsonian features in carriers of GBA1 variant..:

Becker-Cohen, Michal ; Revel-Vilk, Shoshana ; Dinur, Tama...
Molecular Genetics and Metabolism. 138 (2023) 2 - p. 107026 , 2023

Link: https://doi.org/10.1016/..

8

Contribution of Glucosylsphingosine (Lyso-Gb1) to Treatment..:

Tama Dinur ; Peter Bauer ; Christian Beetz...
Molecular Pathology, Diagnostics, and Therapeutics. , 2023

Link: https://doi.org/10.3390/..

9

The Bone Biomarker of Quantitative Chemical Shift Imaging i..:

Ari Zimran ; Jeff Szer ; Michal Becker-Cohen...
https://dx.doi.org/10.3390/jcm12062220. , 2023

Link: https://doi.org/10.3390/..

10

The Bone Biomarker of Quantitative Chemical Shift Imaging i..:

Ari Zimran ; Jeff Szer ; Michal Becker-Cohen...
https://www.mdpi.com/2077-0383/12/6/2220. , 2023

Link: https://doi.org/10.3390/..

11

Contribution of Glucosylsphingosine (Lyso-Gb1) to Treatment..:

Tama Dinur ; Peter Bauer ; Christian Beetz...
https://www.mdpi.com/1422-0067/24/4/3945. , 2023

Link: https://doi.org/10.3390/..

12

A Comprehensive Assessment of Qualitative and Quantitative ..:

Becker-Cohen, Michal ; Zimran, Ari ; Dinur, Tama...
International Journal of Molecular Sciences. 23 (2022) 20 - p. 12211 , 2022

Link: https://doi.org/10.3390/..

13

Prodromal Parkinsonian features invariant carriers:

Becker-Cohen, Michal ; Dinur, Tama ; Katz, Ilana...
Molecular Genetics and Metabolism. 135 (2022) 2 - p. S22 , 2022

Link: https://doi.org/10.1016/..

14

Real-Life Experience with Oral Eliglustat in Patients with ..:

Istaiti, Majdolen ; Becker-Cohen, Michal ; Dinur, Tama..
Journal of Clinical Medicine. 11 (2022) 21 - p. 6265 , 2022

Link: https://doi.org/10.3390/..

15

Markers of inflammation and alpha degranulation defect of p..:

Revel-Vilk, Shoshana ; Naamad, Mira ; Frydman, Dafna...
Molecular Genetics and Metabolism. 135 (2022) 2 - p. S104 , 2022

Link: https://doi.org/10.1016/..